Civic Intelligence

Aim at Melanoma

EIN 56-2427805 • 501(c)3 • Sacramento, CA

View Organization Page

Profile

Aim at melanoma (aim) is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support. Founded in 2004, aim at melanoma is the largest international melanoma foundation seeking the cure for melanoma. Aim believes that the cure for melanoma will be found more quickly by bringing together leading global researchers and funding their collaborative research. Our three paradigm-shifting global research initiatives, including the melanoma tissue bank consortium, are poised to reshape the future of melanoma. Aim is the respected voice of melanoma across the nation. When drugs are approved, legislation is drafted, and research is assessed, aim is at the table, speaking loudly and clearly on behalf of patients and their families. Aim is the trusted advisor for pharmaceutical companies, medical boards, and government agencies on critical topics that affect melanoma patients.

3053 Freeport Blvd Suite 222Sacramento, CA 95818

www.aimatmelanoma.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

15th percentile

0.00x

Higher debt load relative to assets than 15% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Source year 2024

Liabilities / Revenue

14th percentile

0.01x

Higher debt load relative to revenue than 14% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Source year 2024

Net Margin

75th percentile

22%

Higher net margin than 75% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Source year 2024

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

65th percentile

11%

Faster asset growth than 65% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Annualized from 2023 to 2024

Revenue Growth

22nd percentile

-8.5%

Faster revenue growth than 22% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets15th percentile

Assets

Up

$6,666,866

Up $643,491 (+11%) from 2023

Liabilities

Up

$19,708

Up $1,753 (+9.8%) from 2023

Net Assets

Up

$6,647,158

Up $641,738 (+11%) from 2023

Operations
Liabilities / Revenue14th percentileNet Margin75th percentile

Revenue

Down

$2,971,089

Down $274,292 (-8.5%) from 2023

Expenses

Up

$2,329,351

Up $16,003 (+0.7%) from 2023

Net Income

Down

$641,738

Down $290,295 (-31%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth65th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$8.0M$6.0M$4.0M$2.0M$0Assets 2010: $461,059Liabilities 2010: $2,479Net Assets 2010: $458,5802010Assets 2011: $835,775Liabilities 2011: $2,558Net Assets 2011: $833,2172011Assets 2012: $1,120,456Liabilities 2012: $0Net Assets 2012: $1,120,4562012Assets 2013: $1,182,080Liabilities 2013: $0Net Assets 2013: $1,182,0802013Assets 2014: $1,299,576Liabilities 2014: $0Net Assets 2014: $1,299,5762014Assets 2015: $1,680,474Liabilities 2015: $0Net Assets 2015: $1,680,4742015Assets 2016: $2,054,940Liabilities 2016: $0Net Assets 2016: $2,054,9402016Assets 2017: $2,398,753Liabilities 2017: $0Net Assets 2017: $2,398,7532017Assets 2018: $2,573,532Liabilities 2018: $0Net Assets 2018: $2,573,5322018Assets 2019: $3,228,161Liabilities 2019: $121,577Net Assets 2019: $3,106,5842019Assets 2020: $3,672,755Liabilities 2020: $50,000Net Assets 2020: $3,622,7552020Assets 2021: $4,688,149Liabilities 2021: $6,335Net Assets 2021: $4,681,8142021Assets 2022: $5,081,407Liabilities 2022: $8,020Net Assets 2022: $5,073,3872022Assets 2023: $6,023,375Liabilities 2023: $17,955Net Assets 2023: $6,005,4202023Assets 2024: $6,666,866Liabilities 2024: $19,708Net Assets 2024: $6,647,1582024

Highlighted filing

2024

Assets$6,666,866
Liabilities$19,708
Net Assets$6,647,158
Open 2024 Filing

Operations Trend

Revenue Growth22nd percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$4.0M$3.0M$2.0M$1.0M$0Expenses 2010: $746,3772010Expenses 2011: $871,4672011Expenses 2012: $865,7082012Revenue 2013: $1,242,832Expenses 2013: $1,181,208Net Income 2013: $61,6242013Revenue 2014: $1,322,017Expenses 2014: $1,204,521Net Income 2014: $117,4962014Revenue 2015: $1,650,655Expenses 2015: $1,269,757Net Income 2015: $380,8982015Revenue 2016: $1,782,881Expenses 2016: $1,408,415Net Income 2016: $374,4662016Revenue 2017: $2,415,270Expenses 2017: $2,071,457Net Income 2017: $343,8132017Revenue 2018: $2,544,308Expenses 2018: $2,369,528Net Income 2018: $174,7802018Revenue 2019: $2,571,648Expenses 2019: $2,037,762Net Income 2019: $533,8862019Revenue 2020: $2,335,060Expenses 2020: $1,818,889Net Income 2020: $516,1712020Revenue 2021: $2,901,257Expenses 2021: $1,842,198Net Income 2021: $1,059,0592021Revenue 2022: $2,586,311Expenses 2022: $2,194,738Net Income 2022: $391,5732022Revenue 2023: $3,245,381Expenses 2023: $2,313,348Net Income 2023: $932,0332023Revenue 2024: $2,971,089Expenses 2024: $2,329,351Net Income 2024: $641,7382024

Highlighted filing

2024

Revenue$2,971,089
Expenses$2,329,351
Net Income$641,738
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$6,666,866
Liabilities
$19,708
Net assets
$6,647,158
Revenue
$2,971,089
Expenses
$2,329,351
Net income
$641,738
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$6.67$0.02$6.65$2.97$2.33$0.64
2023Detailed filing. Detailed filing data is available for this year.$6.02$0.02$6.01$3.25$2.31$0.93
2022Detailed filing. Detailed filing data is available for this year.$5.08$0.01$5.07$2.59$2.19$0.39
2021Detailed filing. Detailed filing data is available for this year.$4.69$0.01$4.68$2.90$1.84$1.06
2020Detailed filing. Detailed filing data is available for this year.$3.67$0.05$3.62$2.34$1.82$0.52
2019Detailed filing. Detailed filing data is available for this year.$3.23$0.12$3.11$2.57$2.04$0.53
2018Detailed filing. Detailed filing data is available for this year.$2.57$0.00$2.57$2.54$2.37$0.17
2017Detailed filing. Detailed filing data is available for this year.$2.40$0.00$2.40$2.42$2.07$0.34
2016Detailed filing. Detailed filing data is available for this year.$2.05$0.00$2.05$1.78$1.41$0.37
2015Detailed filing. Detailed filing data is available for this year.$1.68$0.00$1.68$1.65$1.27$0.38
2014Detailed filing. Detailed filing data is available for this year.$1.30$0.00$1.30$1.32$1.20$0.12
2013Detailed filing. Detailed filing data is available for this year.$1.18$0.00$1.18$1.24$1.18$0.06
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.12$0.00$1.12$0.87
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.84$0.00$0.83$0.87
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.46$0.00$0.46$0.75
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Jul 17, 2025
Return Version
2024v5.2
Gross Receipts
$3,100,551
Mission and Program Overview

Mission

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support.The AIM at Melanoma website (www.aimatmelanoma.org) is the world's largest most comprehensive melanoma website for patients/caregivers/families. This website is viewed by 40,000 unique users per month in the US, Canada, Australia, and Europe. It serves to educate people around the globe about prevention, early detection, melanoma diagnosis, available treatments, and clinical trials.

To support melanoma research; to promote prevention and education among the general public and medical professionals; and to provide comprehensive and easily accessible melanoma resources for patients, survivors, and caregivers.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$6,005,420$6,647,158▲ $641,738
Savings and Temporary Cash Investments$5,062,268$5,848,509▲ $786,241
Cash and Non-Interest-Bearing Accounts$917,366$772,228▼ $145,138
Intangible Assets$28,094$35,480▲ $7,386
Land, Buildings, and Equipment, Net$15,647$10,649▼ $4,998
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$6,023,375$6,666,866▲ $643,491
Liabilities
Other Liabilities$17,955$19,708▲ $1,753
Total Liabilities$17,955$19,708▲ $1,753
Net Assets / Fund Balance
Total Net Assets Fund Balance$6,005,420$6,647,158▲ $641,738
Total Liabilities and Net Assets / Fund Balance$6,023,375$6,666,866▲ $643,491

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$10,649$54,155$64,804
Compensation and Service Providers
Top Officer PayScore unavailable

Employees

NameTitleFull / Part TimeBaseOtherTotal
Samantha GuildPresident and DirectorFT$179,500$48,774$228,274
Alicia RowellVice PresidentFT$160,008-$160,008

Board Members and Trustees

NameTitle
Howard MaibachDirector
John KirkwoodDirector
Mohammed Kashani-sabetDirector
Renu GuptaDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$2,750,295
Program Service Revenue
$8,315
Investment Income
$212,479
Other Revenue
$0
All Other Contributions
$2,362,114
Change in Net Assets
$641,738

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,750,295
Revenue Not Reported on Financial Statements
$220,794
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$220,794
Total Revenue per Audited Statements
$2,750,295
Total Revenue per Form 990
$2,971,089
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$961,179
Salaries, Compensation, and Employee Benefits$893,172
Grants and Similar Amounts Paid$475,000
Total Fundraising Expense$101,177
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$475,000--$475,000
Other Salaries and Wages$333,273$19,604$39,209$392,086
Current Officers, Directors, Trustees, and Key Employees$338,282$10,225$16,001$364,508
All Other Expenses$125,521-$36,259$161,780
Other Employee Benefits$69,039$3,921$5,465$78,425
Other Expenses$192,376$62,176-$62,176
Payroll Taxes$51,617$2,293$4,243$58,153
Fees for Services Accounting-$36,904-$36,904
Insurance$13,765--$13,765
Occupancy-$10,813-$10,813
Fees for Services Legal$7,082--$7,082
Depreciation Depletion-$6,903-$6,903
Total Functional Expenses$2,075,335$152,839$101,177$2,329,351

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,329,351
Total Expenses per Audited Statements$2,329,351
Total Expenses per Form 990$2,329,351
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Mtbc Melanoma Tissue Bank ConsortiumSacramento, CA-Tissue Bank$475,000
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$129,462
Fundraising Gross Income$129,462
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Steps Against Melanoma Walks$388,181$388,181-$388,181
Total Events$388,181$388,181-$388,181
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Pension Payable$11,625
Credit Card Payable$8,083
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Form 990 is submitted by the accountant to the governing body for review and discussion. The president approves the filing of form 990 based on compliance and accuracy. The accountant is then given authorization to file.”

Form 990, Part VI, Section C, Line 19

“All governing documents, conflict of interest policy and applicable financial statements are available on the organization website and to the public upon request.”

Filing and Contact Details

Filer

Filer Name
Aim at Melanoma
EIN
56-2427805
Phone
9167060599
Address
3053 FREEPORT BLVD SUITE 222, SACRAMENTO, CA 95818

Signing Officer

Name
Samantha Guild
Title
President
Phone
9167060599
Signed
2025-07-17
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Samantha Guild
Formed
2004
Legal Domicile
CA
Voting Board Members
5
Independent Board Members
4
Employees
10
Volunteers
0

Preparer

Firm
Charles M Moche CPA
Address
2050 CENTER AVENUE SUITE 435, FORT LEE, NJ 07024
Preparer
Charles M Moche
Phone
2014651800
Supplemental Narrative

Additional Explanations

Form 990 Part XII Line 2C

“A committee assumes responsibility for the oversight of the audit, review or compilation of its financial statements and selection of its independent auditors. The organization did not change its oversight or selection process during the tax year.”

Financial Statement Notes

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Investment income 212,479. Consulting and honorarium 8,315.”

Raw XML AppendixShowing 400 of 467 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO SUPPORT MELANOMA RESEARCH; TO PROMOTE PREVENTION AND EDUCATION AMONG THE GENERAL PUBLIC AND MEDICAL PROFESSIONALS; AND TO PROVIDE COMPREHENSIVE AND EASILY ACCESSIBLE MELANOMA RESOURCES FOR PATIENTS, SURVIVORS, AND CAREGIVERS.
IRS990/AddressChangeInd0X
IRS990/AllOtherContributionsAmt02362114
IRS990/AllOtherExpensesGrp/FundraisingAmt036259
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0125521
IRS990/AllOtherExpensesGrp/TotalAmt0161780
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum09167060599
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03053 FREEPORT BLVD SUITE 222
IRS990/BooksInCareOfDetail/USAddress/CityNm0SACRAMENTO
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd095818
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0917366
IRS990/CashNonInterestBearingGrp/EOYAmt0772228
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt016001
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt010225
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0338282
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0364508
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0388181
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02750295
IRS990/CYGrantsAndSimilarPaidAmt0475000
IRS990/CYInvestmentIncomeAmt0212479
IRS990/CYOtherExpensesAmt0961179
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt08315
IRS990/CYRevenuesLessExpensesAmt0641738
IRS990/CYSalariesCompEmpBnftPaidAmt0893172
IRS990/CYTotalExpensesAmt02329351
IRS990/CYTotalFundraisingExpenseAmt0101177
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02971089
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt06903
IRS990/DepreciationDepletionGrp/TotalAmt06903
IRS990/Desc0WEBSITEAIM AT MELANOMA ("AIM") IS AN INTERNATIONAL ORGANIZATION ENGAGED IN A WIDE RANGE OF PATIENT ADVOCACY INITIATIVES FOR THE PURPOSE OF RAISING AWARENESS ABOUT MELANOMA AND TO SUPPORT THOSE IMPACTED BY THE DISEASE. AMONG THESE IS THE MAINTENANCE OF THE MOST COMPREHENSIVE U.S. WEBSITE ON MELANOMA (WWW.AIMATMELANOMA.ORG). IN 2024, AIM CONTINUED TO CREATE ADDITIONAL CONTENT FOR THE PURPOSE OF MEETING THEIRTHE NEEDS OF THE MELANOMA COMMUNITY. THIS INCLUDED, BUT WAS NOT LIMITED TO, MAKING IT EASIER FOR USERS TO IDENTIFY PERTINENT INFORMATION TO ASSIST THEM IN BETTER UNDERSTANDING THEIR MELANOMA DIAGNOSIS AND STAGING, TREATMENT OPTIONS, CLINICAL TRIAL OPPORTUNITIES, RECOGNIZE AND MANAGEMENT OF SIDE EFFECTS OF TREATMENT, RISK OF RECURRENCE, FOLLOW-UP CARE, AND THE PSYCHOSOCIAL ASPECTS OF THE DISEASE. THE ORGANIZATION CONTINUED TO USE VARIOUS RESOURCES SUCH AS SEARCH ENGINE OPTIMIZATION, SOCIAL MEDIA, AND BROCHURES DISTRIBUTED TO HEALTHCARE PROVIDERS THROUGHOUT THE U.S, AND OTHER REGIONS OF THE WORLD. TO EDUCATE PATIENTS WITH MELANOMA ABOUT THE WEBSITE'S RESOURCES. THE WEBSITE WAS UPDATED REGULARLY FOR MEDICAL ACCURACY IN ORDER TO REFLECT THE CURRENT STANDARD OF CARE IN MELANOMA AND WITH CONTENT RELATED TO ISSUES FACING THE MELANOMA COMMUNITY. THE U.S. WEBSITE ALONE HAD MORE THAN 88,000 UNIQUE VISITORS EACH MONTH. THIS IS AN INCREASE FROM 2023.PATIENT ADVOCACYTHROUGHOUT 2024, AIM CONTINUED TO PROVIDE A FREE ONCOLOGY PHYSICIAN ASSISTANT ON CALL SERVICE THROUGH ITS ASK AN EXPERT INITIATIVE. PATIENTS WITH MELANOMA, CAREGIVERS, AND FAMILIES REACHED OUT TO ASK QUESTIONS ABOUT, AMONG OTHER THINGS, THEIR/ THEIR LOVED ONE'S MELANOMA DIAGNOSIS, TREATMENT OPTIONS, CLINICAL TRIALS, SIDE EFFECT MANAGEMENT, AND FOLLOW-UP CARE AS WELL AS QUESTIONS REGARDING PREVENTION AND EARLY DETECTION OF THE DISEASE. AIM CONTINUED TO COORDINATE NUMEROUS PATIENT ADVOCACY EVENTS, WHICH INCLUDED 10 PATIENT AND CAREGIVER SYMPOSIA LED BY NATIONALLY RECOGNIZED ONCOLOGISTS WHO SPECIALIZE IN MELANOMA AT MAJOR CANCER CENTERS SUCH AS MD ANDERSON CANCER CENTER, SARAH CANNON, ROSWELL PARK COMPREHENSIVE CANCER CENTER, AND STANFORD CANCER CENTER. THE SYMPOSIA ARE OFFERED AS HYBRID EVENTS SO THAT INDIVIDUALS COULD ATTEND IN-PERSON EVENTS BUT COULD ALSO WATCHED VIA LIVE STREAM. AIM ALSO VIDEOTAPED AND EDITED THESE SYMPOSIUMS, WHICH WERE THEN UPLOADED ONTO YOUTUBE AND AIM'S WEBSITE SO THEY COULD BE VIEWED BY INDIVIDUALS IN THE U.S. AND WORLDWIDE AT ANY TIME. AIM CONTINUED TO PROVIDE SUPPORT FOR PATIENTS, FAMILIES, AND SURVIVORS THROUGH A PROGRAM CALLED PEER CONNECT. PEER CONNECT IS A PEER-TO-PEER SUPPORT PROGRAM, AIM AT MELANOMA'S ANSWER TO THE ONGOING NEED FOR SUPPORT IN THE MELANOMA COMMUNITY. PATIENTS WITH MELANOMA, FAMILY MEMBERS, AND CAREGIVERS WHO JOIN THE PROGRAM ARE MATCHED WITH A PEER, AND FROM THERE THE PAIR COMMUNICATE IN A WAY THAT IS COMFORTABLE FOR BOTH. MEMBERS OF PEER CONNECT PROVIDE EACH OTHER WITH KNOWLEDGE, EXPERIENCE, EMOTIONAL SUPPORT, AND MORE. IN 2024, AIM INCREASED THE NUMBER OF INDIVIDUALS WHO PARTICIPATED IN THE PROGRAM BY 25%. AIM CONTINUES TO MAINTAIN A VERY ACTIVE FACEBOOK PAGE, WITH OVER 26,000 FOLLOWERS, AN X ACCOUNT (FORMERLY KNOWN AS TWITTER) OF OVER 7,650 FOLLOWERS, AN INSTAGRAM ACCOUNT OF OVER 12,000 FOLLOWERS, A YOUTUBE ACCOUNT OF OVER 4,000 SUBSCRIBERS IN ORDER TO PROVIDE OTHER SOURCES OF INFORMATION FOR THE MELANOMA COMMUNITY.AIM CONTINUED TO REPRESENT PATIENTS ON THE TWO LARGEST U.S. COOPERATIVE ONCOLOGY GROUPS, SWOG AND ECOG-ACRIN, THE NCCN, THE ASCO GUIDELINES COMMITTEE, AND THE AAD GUIDELINES OF CARE FOR THE MANAGEMENT OF CUTANEOUS MELANOMA COMMITTEE. AIM ALSO PRESENTED ON THE MELANOMA PATIENT PERSPECTIVE AT NUMEROUS MEETINGS BOTH IN THE U.S. AND THROUGHOUT THE WORLD. TO HELP PATIENTS UNDERSTAND THEIR DISEASE, AIM CONTINUED TO OFFER FROM THE CLINIC TO THE LIVING ROOM, A WEBINAR SERIES THAT IS LIVE STREAMED THROUGH FACEBOOK AND PROVIDES AN IN-DEPTH DISCUSSION ON A SPECIFIC TOPIC WITH A MELANOMA SPECIALIST, SUCH AS AN ONCOLOGIST, RESEAR
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt010
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt02075335
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt036904
IRS990/FeesForServicesAccountingGrp/TotalAmt036904
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt07082
IRS990/FeesForServicesLegalGrp/TotalAmt07082
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt13.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt460.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt423774
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN KIRKWOOD
IRS990/Form990PartVIISectionAGrp/PersonNm1MOHAMMED KASHANI-SABET
IRS990/Form990PartVIISectionAGrp/PersonNm2RENU GUPTA
IRS990/Form990PartVIISectionAGrp/PersonNm3HOWARD MAIBACH
IRS990/Form990PartVIISectionAGrp/PersonNm4SAMANTHA GUILD
IRS990/Form990PartVIISectionAGrp/PersonNm5ALICIA ROWELL
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4204500
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5160008
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4PRESIDENT AND DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5VICE PRESIDENT
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0388181
IRS990/FundraisingDirectExpensesAmt0129462
IRS990/FundraisingGrossIncomeAmt0129462
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt0475000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0475000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0475000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt03100551
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt013765
IRS990/InsuranceGrp/TotalAmt013765
IRS990/IntangibleAssetsGrp/BOYAmt028094
IRS990/IntangibleAssetsGrp/EOYAmt035480
IRS990/InvestmentIncomeGrp/ExclusionAmt0212479
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0212479
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt014
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt054155
IRS990/LandBldgEquipBasisNetGrp/BOYAmt015647
IRS990/LandBldgEquipBasisNetGrp/EOYAmt010649
IRS990/LandBldgEquipCostOrOtherBssAmt064804
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0AIM AT MELANOMA (AIM) IS GLOBALLY ENGAGED AND LOCALLY INVESTED IN ADVANCING THE BATTLE AGAINST MELANOMA THROUGH INNOVATIVE RESEARCH, LEGISLATIVE REFORM, EDUCATION, AND PATIENT AND CAREGIVER SUPPORT. FOUNDED IN 2004, AIM AT MELANOMA IS THE LARGEST INTERNATIONAL MELANOMA FOUNDATION SEEKING THE CURE FOR MELANOMA. AIM BELIEVES THAT THE CURE FOR MELANOMA WILL BE FOUND MORE QUICKLY BY BRINGING TOGETHER LEADING GLOBAL RESEARCHERS AND FUNDING THEIR COLLABORATIVE RESEARCH. OUR THREE PARADIGM-SHIFTING GLOBAL RESEARCH INITIATIVES, INCLUDING THE MELANOMA TISSUE BANK CONSORTIUM, ARE POISED TO RESHAPE THE FUTURE OF MELANOMA. AIM IS THE RESPECTED VOICE OF MELANOMA ACROSS THE NATION. WHEN DRUGS ARE APPROVED, LEGISLATION IS DRAFTED, AND RESEARCH IS ASSESSED, AIM IS AT THE TABLE, SPEAKING LOUDLY AND CLEARLY ON BEHALF OF PATIENTS AND THEIR FAMILIES. AIM IS THE TRUSTED ADVISOR FOR PHARMACEUTICAL COMPANIES, MEDICAL BOARDS, AND GOVERNMENT AGENCIES ON CRITICAL TOPICS THAT AFFECT MELANOMA PATIENTS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt06005420
IRS990/NetAssetsOrFundBalancesEOYAmt06647158
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt010813
IRS990/OccupancyGrp/TotalAmt010813
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt05465
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt03921
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt069039
IRS990/OtherEmployeeBenefitsGrp/TotalAmt078425
IRS990/OtherExpensesGrp/Desc0RESEARCH MEETINGS
IRS990/OtherExpensesGrp/Desc1PATIENT EDUCATION
IRS990/OtherExpensesGrp/Desc2PHYSICIAN/NURSE EDUCATI
IRS990/OtherExpensesGrp/Desc3ADMINISTRATION AND OFFI
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt062176
IRS990/OtherExpensesGrp/ProgramServicesAmt0247215
IRS990/OtherExpensesGrp/ProgramServicesAmt1222165
IRS990/OtherExpensesGrp/ProgramServicesAmt2192376
IRS990/OtherExpensesGrp/TotalAmt0247215
IRS990/OtherExpensesGrp/TotalAmt1222165
IRS990/OtherExpensesGrp/TotalAmt2192376
IRS990/OtherExpensesGrp/TotalAmt362176
IRS990/OtherLiabilitiesGrp/BOYAmt017955
IRS990/OtherLiabilitiesGrp/EOYAmt019708
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt039209
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt019604
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0333273
IRS990/OtherSalariesAndWagesGrp/TotalAmt0392086
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayrollTaxesGrp/FundraisingAmt04243
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt02293
IRS990/PayrollTaxesGrp/ProgramServicesAmt051617
IRS990/PayrollTaxesGrp/TotalAmt058153
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0SAMANTHA GUILD
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0541900
IRS990/ProgramServiceRevenueGrp/BusinessCd1541900
IRS990/ProgramServiceRevenueGrp/Desc0CONSULTING
IRS990/ProgramServiceRevenueGrp/Desc1HONORARIUM
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt07915
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt1400
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt07915
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt1400
IRS990/ProgSrvcAccomActy2Grp/Desc0CONTINUED LINE 4A FROM SCHEDULE ONURSE/PHYSICIAN EDUCATION INITIATIVEIN OCTOBER 2016 AIM CREATED THE MELANOMA NURSING INITIATIVE (MNI). THE RECENT EXPANSION OF MELANOMA THERAPY HAS INCREASED THE COMPLEXITY OF DISEASE MANAGEMENT. PATIENTS WITH MELANOMA MAY DISCONTINUE THERAPY IF NOT ADEQUATELY ENGAGED IN THEIR OWN CARE OR SUPPORTED WHEN THEY EXPERIENCE SIDE EFFECTS. AS WELL, MORE PATIENTS ARE BEING TREATED IN THE COMMUNITY SETTING, WHERE EXPERTISE IS FREQUENTLY LACKING TO ADDRESS THESE CHALLENGES. THE MNI CONSISTS OF:1. MELANOMA NURSE RESOURCE CENTER PORTAL (THEMELANOMANURSE.ORG)THIS PORTAL PROVIDES A 1-STOP SHOP FOR ALL THE EDUCATIONAL MATERIALS DEVELOPEDCONTENT INCLUDES CONSENSUS STATEMENTS, SIDE-EFFECT SEARCH FUNCTIONS, CME ACTIVITIES, A SUPPORTIVE CARE Q/A PORTAL, AND A PATIENT RESOURCE CENTER.2. MELANOMA NURSE MANAGEMENT TOOLKITHELPFUL RESOURCES SUCH AS ALGORITHMS, CHECKLISTS, PRINTABLE SHEETS, AND SEARCHABLE CONTENT ON SUPPORTIVE CARE ASPECTS OF MELANOMA THERAPY (SIDE EFFECT MANAGEMENT AS WELL AS ADHERENCE ISSUES), KEY RESOURCES ON TARGETED THERAPY, IMMUNOTHERAPY, AND INTRALESIONAL IMMUNOTHERAPY ONLINE RESOURCES AS WELL AS PRINT PIECES FOR DISTRIBUTION AT REGIONAL CANCER MEETING.3. CJON (ONS) SUPPLEMENT ON OPTIMIZING OUTCOMES FOR MELANOMA THERAPIES 7-ARTICLE SUPPLEMENT IN CJON TO INCLUDE AN INTRODUCTION BY 2 MELANOMA PHYSICIANS, AN OVERVIEW DOCUMENT FROM OUR CHAIR, AND 5 ARTICLES ON SUPPORT STRATEGIES FOR TARGETED THERAPY, IMMUNOTHERAPY, AND INTRALESIONAL IMMUNOTHERAPY ARTICLES ARE MADE AVAILABLE THROUGH OPEN ACCESS LOCATED ON OUR PORTAL.4. JADPRO SUPPLEMENT ON THE MANAGEMENT OF IMMUNE RELATED ADVERSE EVENTS THIS 4-ARTICLE SUPPLEMENT IN JADPRO COVERS IMMUNO-ONCOLOGY THERAPY ESSENTIALS: PROACTIVE MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS. BOTH THE CJON AND JADPRO SUPPLEMENTS ARE AVAILABLE AS WELL ON THE MNI WEBSITE.5. JCO ONCOLOGY PRACTICE ON INTERDISCIPLINARY CARE FOR MANAGEMENT OF COMPLEX IRAES. THE ARTICLES IN THE SUPPLEMENT COVERS IMMUNO-ONCOLOGY APPLICATIONS IN CLINICAL SCENARIOSINTRODUCTION, TOXICITY MANAGEMENT OF FRONT-LINE PEMBROLIZUMAB COMBINED WITH AXITINIB IN CLEAR CELL METASTATIC RENAL CELL CARCINOMA: A CASE STUDY APPROACH, MANAGEMENT OF PNEUMONITIS AND NEUROPATHY IN PATIENTS RECEIVING PD-1BASED THERAPY FOR NONSMALL-CELL LUNG CANCER, THE MANAGEMENT OF IMMUNE-RELATED DERMATITIS AND MUCOSITIS ASSOCIATED WITH PEMBROLIZUMAB IN METASTATIC HUMAN PAPILLOMAVIRUSASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, AND ATYPICAL PRESENTATIONS AND MANAGEMENT OF ENDOCRINE AND HEPATIC IMMUNE-RELATED ADVERSE EVENTS FROM ADJUVANT IMMUNE CHECKPOINT INHIBITOR THERAPY IN STAGE III RESECTED MELANOMA. THE JCO SUPPLEMENT ARE AVAILABLE AS WELL ON THE MNI WEBSITE.6. AIM CONTINUED TO PROVIDE AN INTERACTIVE, WEB BASED EDUCATION ON BRAF/MEK INHIBITOR THERAPY FOR MELANOMA TO IMPROVE THE OUTCOMES THROUGH INDISCIPLINARY CARE. 7. DEVELOPMENT OF PATIENT RESOURCE MATERIALS CUSTOMIZED PATIENT RESOURCE/EDUCATION MATERIALS (PRINTABLE PDFS) HAVE BEEN DEVELOPED THAT CAN BE DOWNLOADABLE FROM THE WEBSITE AND DISTRIBUTED BY NURSES/PHYSICIAN ASSISTANTS AND OTHER HCPS. TOPICS INCLUDE THE GOALS OF THERAPY, THE SIDE EFFECTS OF THERAPIES, IMPORTANT POINTS/STRATEGIES AROUND ADHERENCE, AS WELL AS OTHER SUPPORTIVE RESOURCES, SUCH AS CALL-IN NUMBERS FOR FINANCIAL OR OTHER ASSISTANCE, ETC. SPECIFIC CONTENT ON TARGETED THERAPIES, IMMUNOTHERAPIES, COMBINATIONS, INTRALESIONAL IMMUNOTHERAPIES, AND THE ADJUVANT SETTING ARE INCLUDED.8. DEVELOPMENT OF PATIENT AND HCP VIDEOS HAVE BEEN DEVELOPED TO ADDRESS THE ISSUES OF PREVENTION AND EARLY DETECTION, SURGERY, PATHOLOGY, TREATMENT, SIDE EFFECTS AND MANAGMENET FOR BOTH TARGETED AND IMMUNOTHERAPIES, CLINICAL TRIALS, AND LIVING WITH MELANOMA. THE HCP VIDEOS WERE DEVELOPED TO ASSIST HCPS TO CARE FOR PATIENTS DURING COVID. THE VIDEOS ARE AVAILABLE ON AIM AT MELANOMA SITE'S YOUTUBE CHANNEL.9. AIM PROVIDED WEB BASED EDUCATION ON STRATEGIES TO SUPPORT SHARED DECISION MAKING IN THE STAGE II SETTING. THE EDUCATION IS AVAILABLE
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt03146314
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0500400
IRS990/PYInvestmentIncomeAmt086535
IRS990/PYOtherExpensesAmt0967256
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt012532
IRS990/PYRevenuesLessExpensesAmt0932033
IRS990/PYSalariesCompEmpBnftPaidAmt0845692
IRS990/PYTotalExpensesAmt02313348
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt03245381
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0641738
IRS990/RegularMonitoringEnfrcInd00
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt06005420
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt06647158
IRS990/SavingsAndTempCashInvstGrp/BOYAmt05062268
IRS990/SavingsAndTempCashInvstGrp/EOYAmt05848509
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02750295
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt03146314
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02571483
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt02730026
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt02133571
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt013331689
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0212479
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt086535
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt05328
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt013358
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt033124
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0350824
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt08315
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt012532
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt09500
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus3YearsAmt0157873
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus4YearsAmt0168365
IRS990ScheduleA/OtherIncome170Grp/TotalAmt0356585
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.47910
IRS990ScheduleA/PublicSupportPY170Pct00.49530
IRS990ScheduleA/PublicSupportTotal170Amt06726547
IRS990ScheduleA/SubstantialContributorsTotAmt06605142
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02750295
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt03146314
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02571483
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt02730026
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt02133571
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt013331689
IRS990ScheduleA/TotalSupportAmt014039098
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02329351
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt010649
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt054155
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt064804
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt011625
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt18083
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0PENSION PAYABLE
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1CREDIT CARD PAYABLE
IRS990ScheduleD/OtherRevenuesNotIncludedAmt0220794
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt0220794
IRS990ScheduleD/RevenueSubtotalAmt02750295
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0INVESTMENT INCOME 212,479. CONSULTING AND HONORARIUM 8,315.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART XI, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt010649
IRS990ScheduleD/TotalExpensesPerForm990Amt02329351
IRS990ScheduleD/TotalLiabilityAmt019708
IRS990ScheduleD/TotalRevenuePerForm990Amt02971089
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt02750295
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt02329351
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0STEPS AGAINST MELANOMA WALKS
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt0388181
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt0388181
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt0388181
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt0388181
IRS990ScheduleG/FundraisingEventInformationGrp/NetIncomeSummaryAmt0388181
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0475000
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0TISSUE BANK
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0MTBC MELANOMA TISSUE BANK CONSORTIUM
IRS990ScheduleI/RecipientTable/RecipientEIN0462454076
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01779 MARKHAM WAY
IRS990ScheduleI/RecipientTable/USAddress/CityNm0SACRAMENTO
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0CA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd095818
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/EquityBasedCompArrngmInd00
IRS990ScheduleJ/Form990OfOtherOrganizationsInd0X
IRS990ScheduleJ/InitialContractExceptionInd00
IRS990/ScheduleJRequiredInd01
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt0179500
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt1160008
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount025000
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt023774
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm0SAMANTHA GUILD
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm1ALICIA ROWELL
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt0PRESIDENT AND DIRECTOR
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt1VICE PRESIDENT
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt0228274
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt1160008
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt10
IRS990ScheduleJ/SeverancePaymentInd00
IRS990ScheduleJ/SupplementalNonqualRtrPlanInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FORM 990 IS SUBMITTED BY THE ACCOUNTANT TO THE GOVERNING BODY FOR REVIEW AND DISCUSSION. THE PRESIDENT APPROVES THE FILING OF FORM 990 BASED ON COMPLIANCE AND ACCURACY. THE ACCOUNTANT IS THEN GIVEN AUTHORIZATION TO FILE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND APPLICABLE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION WEBSITE AND TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2A COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT, REVIEW OR COMPILATION OF ITS FINANCIAL STATEMENTS AND SELECTION OF ITS INDEPENDENT AUDITORS. THE ORGANIZATION DID NOT CHANGE ITS OVERSIGHT OR SELECTION PROCESS DURING THE TAX YEAR.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990 PART XII LINE 2C
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt06023375
IRS990/TotalAssetsEOYAmt06666866
IRS990/TotalAssetsGrp/BOYAmt06023375
IRS990/TotalAssetsGrp/EOYAmt06666866
IRS990/TotalCompGreaterThan150KInd01

Document Assets

No mirrored PDF or thumbnail assets are attached yet.